Get started
Author

Jun Ding

ORCID: 0000-0002-5923-3621
Observed ORCID: 0000-0002-5923-3621
OpenAlex ID: A5112531090
Induction of Durable Antitumor Response by a Novel Oncolytic Herpesvirus Expressing Multiple Immunomodulatory Transgenes
2020 · Dmitry V. Chouljenko, Jun Ding, et al. · Biomedicines · 62
PDF
A Novel Self‐Amplifying mRNA with Decreased Cytotoxicity and Enhanced Protein Expression by Macrodomain Mutations
2024 · Yue Gong, Danni Yong, et al. · Advanced Science · 46
PDF
VG161 activates systemic antitumor immunity in pancreatic cancer models as a novel oncolytic herpesvirus expressing multiple immunomodulatory transgenes
2022 · Yinan Shen, Wei Song, et al. · Journal of Medical Virology · 37
PDF
Pre-Existing HSV-1 Immunity Enhances Anticancer Efficacy of a Novel Immune-Stimulating Oncolytic Virus
2022 · Jun Ding, Yanal M. Murad, et al. · Viruses · 33
PDF
Combination of novel oncolytic herpesvirus with paclitaxel as an efficient strategy for breast cancer therapy
2023 · Xinyue Deng, Yinan Shen, et al. · Journal of Medical Virology · 25
PDF
Targeting carcinoembryonic antigen-expressing tumors using a novel transcriptional and translational dual-regulated oncolytic herpes simplex virus type 1
2023 · Dmitry V. Chouljenko, Yanal M. Murad, et al. · Molecular Therapy — Oncolytics · 15
Prevention and treatment of HPV‐related cancer through a mRNA vaccine expressing APC‐targeting antigen
2024 · Xiaoxuan Li, Huiyan Wang, et al. · Immunology · 14
PDF
Heterologous prime-boost with an mRNA vaccine and an oncolytic virus enhances tumor regression through overcoming intratumoral immune suppression
2025 · Kuan Zhang, Dong Zuo, et al. · Cell Reports · 10
A TRAMP‐derived orthotopic prostate syngeneic (TOPS) cancer model for investigating anti‐tumor treatments
2018 · Justin Lardizabal, Jun Ding, et al. · The Prostate · 10
[Isolation of the Culex flavivirus from mosquitoes in Liaoning Province, China].
2012 · Shu-Yi An, Jia-Song Liu, et al. · PubMed · 8
Oncolytic virotherapy stimulates anti‑tumor immune response and demonstrates activity in advanced sarcoma: Report of two cases
2024 · Yeting Qiu, Aijun Qin, et al. · Oncology Letters · 5
PDF
Prophylactic Vaccination and Intratumoral Boost with HER2-Expressing Oncolytic Herpes Simplex Virus Induces Robust and Persistent Immune Response against HER2-Positive Tumor Cells
2023 · Zahid Delwar, Olga Tatsiy, et al. · Vaccines · 4
PDF
[Isolation and identification of arboviruses from mosquito pools in some regions of Liaoning province, China].
2009 · Wei-Shan Meng, Ji-Bo Zhang, et al. · PubMed · 4
Hypothesis-generating evaluation of multi-armoured oncolytic HSV-1 (VG161) in intrahepatic cholangiocarcinoma: pooled insights from multicentre studies
2025 · Yinan Shen, Xinyan Jin, et al. · Gut · 2
The initial report of phase I trial of VG2025, a non-attenuated HSV-1 oncolytic virus expressing IL-12 and IL-15/RA payloads, in patients with advanced solid tumors.
2023 · Siqing Fu, Madappa N. Kundranda, et al. · Journal of Clinical Oncology · 2
PDF
Oncolytic virus VG161 in combination with camrelizumab as second-line therapy in patients with advanced primary hepatocellular carcinoma: A phase Ib/IIa clinical study.
2025 · Yinan Shen, Xingmei Liang, et al. · Journal of Clinical Oncology · 1
PDF
HSV-1 Oncolytic Virus Targeting CEACAM6-Expressing Tumors Using a Bispecific T-Cell Engager
2023 · Yanal M. Murad, I-Fang Lee, et al. · bioRxiv (Cold Spring Harbor Laboratory) · 1
PDF
Abstract 5205: VG2025: Transcriptional and translational dually regulated (TTDR) oncolytic virus for cancer immunotherapy
2022 · Yanal Murad, Guoyu Liu, et al. · Cancer Research · 1
Abstract B059: Synergistic activation of antitumor immunity by an oncolytic virus VG161 armed with multiple immune-stimulating genes
2019 · Ronghua Zhao, Jun Ding, et al. · Cancer Immunology Research · 1
[Genotype 1 JEV was isolated again from Liaoning Province, China, 2007].
2008 · Wei-shan Meng, Ming-hua Li, et al. · PubMed · 1
Abstract 1913: Pre-existing HSV-1 Immunity enhances anti-cancer efficacy of a novel immune stimulating oncolytic virus - VG161
2021 · Jun Ding, Jason Sun, et al. · Cancer Research
Abstract B85: Anticancer efficacy of a novel immune-stimulating oncolytic virus: VG161 in gastrointestinal cancers
2020 · Ronghua Zhao, Jun Ding, et al. · Cancer Immunology Research
The novel biomarkers in diagnosis of prostate cancer
2019 · Qi Liu, Jun Ding, et al. · Cancer Plus
Abstract 5641: Synergy of immunomodulators delivered by an HSV-1 oncolytic virus can enhance its therapeutic effects in vivo
2018 · Yanal M. Murad, Jun Ding, et al. · Cancer Research
Works count: 24
Citation count: 282
H-index: 9
I10-index: 9
Year
Topic
Type